Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

CVS Health : to Buy Aetna for $69 Billion -- Update

share with twitter share with LinkedIn share with facebook
share via e-mail
12/03/2017 | 02:21pm EDT
By Dana Cimilluca, Dana Mattioli and Anna Mathews 

CVS Health Corp. has agreed to buy Aetna Inc. for about $69 billion in cash and stock, a landmark deal that would change the U.S. health-care landscape by bringing a large insurer and a big provider of pharmacy services under one roof.

In an agreement that has been months in the making and is likely to be announced later Sunday, Aetna stockholders are to receive $207 per share, $145 in cash and $62 in stock, according to people familiar with the matter.

As part of the deal, CVS plans to use its nearly 10,000 pharmacy locations to provide consumers with more local care options.

The deal -- the biggest announced in more than a year -- pulls together two giants from very different corners of the health-care industry. CVS, with annual revenue of $178 billion, is a major pharmacy-benefits manager in addition to its vast collection of drugstores, some of which already have retail clinics. Aetna, with revenue of around $63 billion, is the third-largest U.S. health insurer, providing coverage to around 22.2 million members enrolled in employer, Medicare, Medicaid and other plans.

Both companies have challenges in their core businesses. CVS faces the potential threat of Amazon.com Inc., which may enter the pharmacy business.

Aetna was forced earlier this year to give up its planned acquisition of Humana Inc. and has retreated from the money-losing Affordable Care Act exchange business, leaving it with an unclear path to future growth, analysts say. It also lacks the diversity of larger rival UnitedHealth Group Inc., which has a fast-expanding health-services arm that includes a pharmacy-benefits manager as well as doctor practices and surgery centers.

The deal "feels more defense than offense," Ana Gupte, an analyst with Leerink Partners LLC, said recently. In Aetna's case, "I don't see a path to growth" in its current configuration, she said.

The combination faces substantial challenges, including the huge operational task of knitting together the companies' diverse operations so that customer experiences are smooth and seamless. The deal isn't likely to deliver as many cost-cutting benefits as combinations with more direct overlap, such as Aetna's scuttled acquisition of Humana, analysts said. CVS will need to keep much of Aetna's infrastructure since it doesn't currently provide health insurance.

CVS plans to repurpose portions of its pharmacies so they become community health centers where customers can go to get answers to more questions about their health and coverage, the companies plan to announce. The pharmacies will have space dedicated to wellness, and provide services for things like vision, hearing and nutrition.

Write to Dana Cimilluca at dana.cimilluca@wsj.com, Dana Mattioli at dana.mattioli@wsj.com and Anna Mathews at anna.mathews@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 1.84% 59.68 Delayed Quote.-19.67%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CVS HEALTH CORPORATION
03/28ALASKA AIR GROUP, FORD MOTOR, CVS HE : Stocks That Defined the Week
DJ
03/26CVS HEALTH : Pandemic Will Hurt Financial Results, Full Scope Not Yet Clear
DJ
03/26CVS HEALTH CORP : Other Events (form 8-K)
AQ
03/26CVS HEALTH : tapping furloughed hotel workers to fill jobs
AQ
03/25CVS HEALTH : Aetna to Waive Cost-sharing Charges for Hospital Admissions for Cov..
DJ
03/25CVS HEALTH : Aetna waives patient payments for coronavirus hospital stays
AQ
03/24CVS HEALTH : CEO Says Supply of Pharmaceuticals Remains Steady
DJ
03/24LARRY MERLO : CVS Health CEO Merlo Says Supply of Pharmaceuticals Remains Steady
DJ
03/23Coronavirus Sparks Hiring Spree for Nearly 500,000 Jobs at Big Retailers -- 2..
DJ
03/23Coronavirus Sparks Hiring Spree for Nearly 500,000 Jobs at Big Retailers -- U..
DJ
More news
Financials (USD)
Sales 2020 263 B
EBIT 2020 15 733 M
Net income 2020 7 302 M
Debt 2020 55 076 M
Yield 2020 3,35%
P/E ratio 2020 10,7x
P/E ratio 2021 9,60x
EV / Sales2020 0,51x
EV / Sales2021 0,46x
Capitalization 77 832 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 80,77  $
Last Close Price 59,68  $
Spread / Highest target 82,6%
Spread / Average Target 35,3%
Spread / Lowest Target -1,14%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors